Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-188853
Filing Date
2024-07-30
Accepted
2024-07-30 16:06:46
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d873714d10q.htm   iXBRL 10-Q 1076318
2 EX-3.1 d873714dex31.htm EX-3.1 75012
3 EX-31.1 d873714dex311.htm EX-31.1 10291
4 EX-31.2 d873714dex312.htm EX-31.2 10297
5 EX-32.1 d873714dex321.htm EX-32.1 5380
  Complete submission text file 0001193125-24-188853.txt   5195881

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20240630.xsd EX-101.SCH 43707
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dbvt-20240630_cal.xml EX-101.CAL 43095
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20240630_def.xml EX-101.DEF 202098
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20240630_lab.xml EX-101.LAB 301062
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20240630_pre.xml EX-101.PRE 267736
76 EXTRACTED XBRL INSTANCE DOCUMENT d873714d10q_htm.xml XML 821486
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36697 | Film No.: 241157370
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)